Simvastatin price December 2025 and outlook (see chart below)
- India:US$173.2/KG, -2.6% down
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Simvastatin price index
This post is a summary of the Simvastatin price developments. The price developments of Simvastatin are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Simvastatin price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Simvastatin prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Simvastatin prices
- Recent price developments of underlying feedstocks which drive the price of Simvastatin
- Market futures for both cost drives and feedstocks of Simvastatin prices
- Adjustment of current supply/demand imbalances in the Simvastatin market
- Longer term trends in likely demand conditions
What is Simvastatin and what is it used for
Simvastatin is a member of the statin class of lipid-lowering medicines used to reduce blood levels of low-density lipoprotein (LDL) cholesterol and to help prevent cardiovascular events (heart attacks, strokes) in people at risk. It is prescribed alongside diet, exercise and other measures for treatment of high cholesterol and for primary and secondary prevention of atherosclerotic cardiovascular disease.
How is Simvastatin
Simvastatin is an oral medication (tablet) that is a semi-synthetic derivative of earlier statins; it works by inhibiting HMG-CoA reductase, the key liver enzyme in cholesterol synthesis, which lowers the liver’s production of cholesterol and increases removal of LDL from the bloodstream. Typical dosing and safety considerations (drug–drug interactions, dose adjustments, pregnancy/breastfeeding cautions) are defined in national guidance and product labels.
How large is the global market for Simvastatin
Market research firms report that the simvastatin drug market is measured in the multi-billion USD range and is growing modestly (reports for 2024–2025 estimate global simvastatin market values in the low-to-mid single-digit billions with projected CAGR in the mid single digits through the late 2020s). Exact figures vary by source and by whether studies measure simvastatin alone or the broader statin market—so published estimates should be checked for the year and methodology used.
Where is it produced
Simvastatin is widely available as a generic medicine and its active pharmaceutical ingredient (API) and finished products are manufactured globally. Major producers include established generic drug manufacturers in India and other generic producers (many companies hold approvals for simvastatin APIs and tablets), and there are specialist API suppliers in Europe and elsewhere that support global supply chains. Companies and CDMOs that supply simvastatin API and finished dosages are located in India, China, parts of Europe and Puerto Rico, among other regions.